Literature DB >> 21410800

Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide?

Otto Kučera1, Halka Lotková, Pavla Staňková, Miroslav Podhola, Tomáš Roušar, Vojtěch Mezera, Zuzana Cervinková.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic condition of the liver in the western world. There is only little evidence about altered sensitivity of steatotic liver to acute toxic injury. The aim of this project was to test whether hepatic steatosis sensitizes rat liver to acute toxic injury induced by thioacetamide (TAA). Male Sprague-Dawley rats were fed ad libitum a standard pelleted diet (ST-1, 10% energy fat) and high-fat gelled diet (HFGD, 71% energy fat) for 6 weeks and then TAA was applied intraperitoneally in one dose of 100 mg/kg. Animals were sacrificed in 24-, 48- and 72-h interval after TAA administration. We assessed the serum biochemistry, the hepatic reduced glutathione, thiobarbituric acid reactive substances, cytokine concentration, the respiration of isolated liver mitochondria and histopathological samples (H+E, Sudan III, bromodeoxyuridine [BrdU] incorporation). Activities of alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase and concentration of serum bilirubin were significantly higher in HFGD groups after application of TAA, compared to ST-1. There were no differences in activities of respiratory complexes I and II. Serum tumour necrosis factor alpha at 24 and 48 h, liver tissue interleukin-6 at 72 h and transforming growth factor β1 at 24 and 48 h were elevated in TAA-administrated rats fed with HFGD, but not ST-1. TAA-induced centrilobular necrosis and subsequent regenerative response of the liver were higher in HFGD-fed rats in comparison with ST-1. Liver affected by NAFLD, compared to non-steatotic liver, is more sensitive to toxic effect of TAA.
© 2011 The Authors. International Journal of Experimental Pathology © 2011 International Journal of Experimental Pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21410800      PMCID: PMC3144517          DOI: 10.1111/j.1365-2613.2011.00765.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  42 in total

Review 1.  Glutathione metabolism and its implications for health.

Authors:  Guoyao Wu; Yun-Zhong Fang; Sheng Yang; Joanne R Lupton; Nancy D Turner
Journal:  J Nutr       Date:  2004-03       Impact factor: 4.798

2.  High-fat emulsion-induced rat model of nonalcoholic steatohepatitis.

Authors:  Yuhong Zou; Jun Li; Chao Lu; Jianqing Wang; Jinfang Ge; Yan Huang; Lei Zhang; Yuanyuan Wang
Journal:  Life Sci       Date:  2006-03-24       Impact factor: 5.037

3.  A high-yield preparative method for isolation of rat liver mitochondria.

Authors:  E Bustamante; J W Soper; P L Pedersen
Journal:  Anal Biochem       Date:  1977-06       Impact factor: 3.365

4.  Saturation toxicokinetics of thioacetamide: role in initiation of liver injury.

Authors:  Jaya Chilakapati; Kartik Shankar; Midhun C Korrapati; Ronald A Hill; Harihara M Mehendale
Journal:  Drug Metab Dispos       Date:  2005-09-23       Impact factor: 3.922

5.  Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice.

Authors:  K Kovalovich; R A DeAngelis; W Li; E E Furth; G Ciliberto; R Taub
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

6.  Curcumin ameliorates acute thioacetamide-induced hepatotoxicity.

Authors:  Haim Shapiro; Michal Ashkenazi; Nir Weizman; Mark Shahmurov; Hussein Aeed; Rafael Bruck
Journal:  J Gastroenterol Hepatol       Date:  2006-02       Impact factor: 4.029

7.  Determination of reduced and oxidized glutathione in biological samples using liquid chromatography with fluorimetric detection.

Authors:  Roman Kand'ár; Pavla Záková; Halka Lotková; Otto Kucera; Zuzana Cervinková
Journal:  J Pharm Biomed Anal       Date:  2006-12-19       Impact factor: 3.935

8.  Epidermal growth factor reduces multiorgan failure induced by thioacetamide.

Authors:  M E Caballero; J Berlanga; D Ramirez; P Lopez-Saura; R Gozalez; D N Floyd; T Marchbank; R J Playford
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

9.  Thioacetamide-induced hepatic damage in a rat nutritional model of steatohepatitis.

Authors:  Yona Avni; Haim Shirin; Hussein Aeed; Mark Shahmurov; Shlomo Birkenfeld; Rafael Bruck
Journal:  Hepatol Res       Date:  2004-11       Impact factor: 4.288

10.  Tert-butyl hydroperoxide selectively inhibits mitochondrial respiratory-chain enzymes in isolated rat hepatocytes.

Authors:  Z Drahota; P Kriváková; Z Cervinková; E Kmonícková; H Lotková; O Kucera; J Houstek
Journal:  Physiol Res       Date:  2005       Impact factor: 1.881

View more
  4 in total

1.  The effect of tert-butyl hydroperoxide-induced oxidative stress on lean and steatotic rat hepatocytes in vitro.

Authors:  Otto Kučera; René Endlicher; Tomáš Roušar; Halka Lotková; Tomáš Garnol; Zdeněk Drahota; Zuzana Cervinková
Journal:  Oxid Med Cell Longev       Date:  2014-03-31       Impact factor: 6.543

2.  Jiang-Zhi granules decrease sensitivity to low-dose CCl4 induced liver injury in NAFLD rats through reducing endoplasmic reticulum stress.

Authors:  Lili Yang; Yan Zhou; Haiyan Song; Peiyong Zheng
Journal:  BMC Complement Altern Med       Date:  2019-08-22       Impact factor: 3.659

3.  Decreased translation of Dio3 mRNA is associated with drug-induced hepatotoxicity.

Authors:  Kate M Dudek; Laura Suter; Veerle M Darras; Emma L Marczylo; Timothy W Gant
Journal:  Biochem J       Date:  2013-07-01       Impact factor: 3.857

4.  Coenzyme Q10 supplementation improves metabolic parameters, liver function and mitochondrial respiration in rats with high doses of atorvastatin and a cholesterol-rich diet.

Authors:  Ma Antonia Jiménez-Santos; Isela E Juárez-Rojop; Carlos A Tovilla-Zárate; María Teresa Espinosa-García; Marco A Juárez-Oropeza; Teresa Ramón-Frías; Deysi Y Bermúdez-Ocaña; Juan C Díaz-Zagoya
Journal:  Lipids Health Dis       Date:  2014-01-25       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.